Key Features Research-Grade Quality: Manufactured to support professional laboratory and scientific research standards
Where is another common area that patients report concerns for cellulite
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Pinch a fold of skin, insert the needle at a 90-degree angle, and push the plunger steadily until all medication is delivered
NNMT inhibition follows dose-dependent curves: 50mg produces 4050% enzyme inhibition, 100mg achieves 6075%, with diminishing returns beyond 150mg
We also suggested that, as was advocated by the RCGP a week or two earlier, that patients be instructed on how to self-administer their injections
